Keros Therapeutics
KROS
$57.10
Share price
-1.07%
Change (1 day)
26.97%
Change (1 year)
Categories
Keros Therapeutics (KROS) - Total liabilities
Total liabilities on the balance sheet as of December 2023 : $37.81 M
According to Keros Therapeutics's latest financial reports the company's total liabilities are $37.81 M. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Keros Therapeutics - Total liabilities on balance sheet (from 2019 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023-12-31 | $37.81 M | 28.8% |
| 2022-12-31 | $29.35 M | 143.09% |
| 2021-12-31 | $12.07 M | 56.4% |
| 2020-12-31 | $7.72 M | -26.18% |
| 2019-12-31 | $10.46 M | -28.62% |
| 2018-12-31 | $14.65 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $27.91 M | -26.16% | 🇺🇸 USA |